| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| UMICORE | 2 | 2 | -0,41 % | ||
| LOTUS BAKERIES | 2 | - | 0,00 % | ||
| AB INBEV | - | 30 | -0,19 % | ||
| ARGENX | - | 10 | -0,03 % | ||
| MELEXIS | - | 4 | -0,19 % | ||
| ELIA GROUP | - | 4 | -0,63 % | ||
| AGEAS | - | 1 | -0,16 % | ||
| KBC GROEP NV | - | 1 | -0,29 % | ||
| GBL | - | 1 | -0,49 % | ||
| MONTEA | - | 1 | +0,14 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Umicore - Transparency notifications by BlackRock, Inc. | 7 | GlobeNewswire (USA) | ||
| Fr | Umicore - Transparency notifications by Amundi SA | 9 | GlobeNewswire (USA) | ||
| Fr | LOTUS BAKERIES: 2025 Annual Results Lotus Bakeries (NL version) | 2 | Euronext | ||
| Fr | Lotus Bakeries lifts dividend after strong year | 7 | belga | ||
| Fr | 2025 Annual Results Lotus Bakeries | 13 | Euronext | ||
| Fr | JPMORGAN stuft AB Inbev auf 'Overweight' | 428 | dpa-AFX-Analyser | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für AB Inbev mit einem Kursziel von 73 Euro auf "Overweight" belassen. AB Inbev überzeuge mit der besten Gewinnentwicklung je Aktie... ► Artikel lesen | |
| Do | UCB announces new positive data on Bimzelx in hidradenitis suppurativa | 9 | PMLiVE | ||
| Do | AB InBev veteran named Lamb Weston executive chair | 5 | Just Food | ||
| Mi | Melexis posts lower sales and profit as outlook disappoints | 6 | belga | ||
| Mi | Melexis: Schwacher Ausblick für H1-26 wegen verhaltener Automobilnachfrage | 22 | Investing.com Deutsch | ||
| Mi | Syensqo SA: Participation notification by BlackRock Inc. | 2.284 | GlobeNewswire (Europe) | Press releaseCommuniqué de pressePersbericht
Regulated
Participation notification by BlackRock Inc.
Brussels, Belgium - February 04, 2026 - 08:30 CET
According to Belgian transparency... ► Artikel lesen | |
| Mi | Solvay weiht Europas erste bio-zirkuläre Silica-Anlage in Italien ein | 22 | Chemie.de | ||
| Mi | ANHEUSER-BUSCH INBEV SA/NV - AB InBev reports on the progress of its share buy-back program announced on 30 October 2025 | 23 | SENS | ||
| Di | Belgian to head AB InBev France | 13 | RetailDetail | ||
| Mo | GBL: GBL - Transactions on GBL shares 02-02-2026 | 2 | Euronext | ||
| Mo | GBL: GBL - Voting rights and denominator - Situation as at January 31, 2026 | 1 | Euronext | ||
| Mo | UCB bags first EU approval for rare genetic disease TK2d | 11 | pharmaphorum |